3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
4
Status
Completed
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Gastrointestinal
4
Genitourinary
2
Breast
1
Conditions
Motor Activity
20
Polycystic Ovary Syndrome
10
Prostatic Neoplasms
7
Breast Neoplasms
6
Neoplasms
5
Colorectal Neoplasms
4
Insulin Resistance
3
Lung Neoplasms
2
Fatigue
2
Esophageal Neoplasms
2
Cardiotoxicity
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Primary Dysautonomias
1
Pediatric Brain Tumor
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Lupus Erythematosus, Systemic
1
Inflammation
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Disease
1
Diabetes Mellitus, Type 1
1
Chemotherapy-Related Cognitive Impairment
1
Cardiovascular Diseases
1
Interventions
Oxaliplatin
269
Bevacizumab
259
Fluorouracil
248
Irinotecan
240
Leucovorin
217
Capecitabine
196
Cetuximab
160
Colonoscopy
74
Folfox protocol
70
Panitumumab
64
regorafenib
62
Drug Therapy
52
Radiotherapy
50
HMPL-013
50
Blood Specimen Collection
45
trifluridine tipiracil drug combination
43
pembrolizumab
41
Surveys and Questionnaires
35
Standard of Care
34
Nivolumab
34
Neoadjuvant Therapy
34
Surgical Procedures, Operative
33
Magnetic Resonance Spectroscopy
30
IFL protocol
27
Trifluridine
26
Interviews as Topic
26
Celecoxib
26
XELOX
25
Early Intervention, Educational
24
Methods
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
OTHER
×
Colorectal Neoplasms
×
High-Intensity Interval Training
×
Clear all
NCT04558398
2026-04-29
ICCE-Mito
University of Nottingham
Phase NA
Completed
15 enrolled
NCT04923672
2024-10-16
ExPre 01
University of Virginia
Phase NA
Terminated
10 enrolled
NCT02473003
2023-12-21
Phys-Can
Uppsala University
Phase NA
Unknown
600 enrolled
NCT04715061
2022-11-07
CANEX-2
Université de Sherbrooke
Phase NA
Completed
19 enrolled